Gene expression analysis by cDNA microarray in oral squamous cell carcinoma

被引:56
作者
Tomioka, H
Morita, K
Hasegawa, S
Omura, K
机构
[1] Tokyo Med & Dent Univ, Dept Oral Resitut, Div Oral Hlth Sci, Grad Sch,Bunkyo Ku, Tokyo 1138549, Japan
[2] Tokyo Med & Dent Univ, Ctr Excellence Program Mol Destruct & Reconstruct, Bunkyo Ku, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Dept Adv Mol Diagnosis & Maxillofacial Surg, Bunkyo Ku, Tokyo, Japan
关键词
cDNA microarray; gene expression; oral cancer; squamous cell carcinoma;
D O I
10.1111/j.1600-0714.2006.00410.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Oral squamous cell carcinoma (OSCC) is common type of human cancer, but little is known about the molecular mechanisms deciding on this malignancy. Comprehensive gene expression profiling is essential for understanding OSCC. Methods: cDNA microarray was used to analyze expression patterns of 16 617 genes in nine OSCC patients. Results: Forty-seven genes with altered expression among all cases were extracted. The ontology of these 47 genes was classified into 10 categories. To validate the microarray data, the expression of genes, including TGFBI, FADD and DUSP1 was analyzed by reverse transcriptase-polymerase chain reaction (RT-PCR). By hierarchical clustering analysis, the nine cases were divided into two clusters. Conclusions: The 47 genes are suggested as having a functional significance in oral squamous cell carcinogenesis. It is also suggested that the gene expression patterns by hierarchical clustering analysis can represent degrees of differentiation. The postoperative recovery was uneventful and patients free from tumor after surgery. In the future, on the occasion when the time comes that the number of cases accumulated for microarray increases and each case is observed more over a long-term, these data of 5-year survival rate will be added. Thereby, it will become possible to represent the malignancy of OSCC by these gene expression patterns.
引用
收藏
页码:206 / 211
页数:6
相关论文
共 24 条
[1]  
ALESSI DR, 1993, ONCOGENE, V8, P2015
[2]   Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma [J].
Cheng, Q ;
Lau, WM ;
Tay, SK ;
Chew, SH ;
Ho, TH ;
Hui, KM .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) :419-426
[3]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[4]   Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma [J].
Denkert, C ;
Schmitt, WD ;
Berger, S ;
Reles, A ;
Pest, S ;
Siegert, A ;
Lichtenegger, W ;
Dietel, M ;
Hauptmann, S .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (05) :507-513
[5]   Fas engagement induces neurite growth through ERK activation and p35 upregulation [J].
Desbarats, J ;
Birge, RB ;
Mimouni-Rongy, M ;
Weinstein, DE ;
Palerme, JS ;
Newell, MK .
NATURE CELL BIOLOGY, 2003, 5 (02) :118-125
[6]   Expression profiling using cDNA microarrays [J].
Duggan, DJ ;
Bittner, M ;
Chen, YD ;
Meltzer, P ;
Trent, JM .
NATURE GENETICS, 1999, 21 (Suppl 1) :10-14
[7]   Skp2 is oncogenic and overexpressed in human cancers [J].
Gstaiger, M ;
Jordan, R ;
Lim, M ;
Catzavelos, C ;
Mestan, J ;
Slingerland, J ;
Krek, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) :5043-5048
[8]  
Hu YC, 2001, CLIN CANCER RES, V7, P3519
[9]   A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region [J].
Hua, ZC ;
Sohn, SJ ;
Kang, CH ;
Cado, D ;
Winoto, A .
IMMUNITY, 2003, 18 (04) :513-521
[10]   High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells [J].
Huang, X ;
Gollin, SM ;
Raja, S ;
Godfrey, TE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11369-11374